Evidence map›Paper›PMID 29171432›Full record

ArticleNeural regeneration research2017

Locomotor analysis identifies early compensatory changes during disease progression and subgroup classification in a mouse model of amyotrophic lateral sclerosis.

Melissa M Haulcomb, Rena M Meadows, Whitney M Miller, Kathryn P McMillan, MeKenzie J Hilsmeyer, Xuefu Wang, Wesley T Beaulieu, Stephanie L Dickinson, Todd J Brown, Virginia M Sanders and 1 more

Open access · goldAbstract read
In one paragraph

Article in Neural regeneration research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Melissa M HaulcombDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN; Research and Development Service, Roudebush Veterans Administration Medical Center, Indianapolis, IN, USA.
Rena M MeadowsDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN; Research and Development Service, Roudebush Veterans Administration Medical Center, Indianapolis, IN; Program in Medical Neurosciences, Indiana University School of Medicine, Indianapolis, IN, USA.
Whitney M MillerDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN; Research and Development Service, Roudebush Veterans Administration Medical Center, Indianapolis, IN, USA.
Kathryn P McMillanDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN; Research and Development Service, Roudebush Veterans Administration Medical Center, Indianapolis, IN, USA.
MeKenzie J HilsmeyerDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, USA.
Xuefu WangDepartment of Statistics, Indiana University, Bloomington, IN, USA.
Wesley T BeaulieuDepartment of Statistics, Indiana University, Bloomington, IN, USA.
Stephanie L DickinsonDepartment of Statistics, Indiana University, Bloomington, IN; Department of Epidemiology and Biostatistics, Indiana University, Bloomington, IN, USA.
Todd J BrownDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN; Research and Development Service, Roudebush Veterans Administration Medical Center, Indianapolis, IN, USA.
Virginia M SandersDepartment of Cancer Biology and Genetics, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Kathryn J JonesDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN; Research and Development Service, Roudebush Veterans Administration Medical Center, Indianapolis, IN, USA.
Richard L. Roudebush VA Medical Center · USIndiana University Bloomington · USIndiana University – Purdue University Indianapolis · USIndiana University School of MedicineThe Ohio State University Wexner Medical Center · US

Funding

Immune Regulation of Neuronal Injury and RepairR01NS040433 · NINDS · LOYOLA UNIVERSITY CHICAGO · PI JONES, KATHRYN JANE · 2001 to 2017
$5.9M
NINDS NIH HHS R01 NS040433
6 · The paper itself

Abstract

Amyotrophic lateral sclerosis is a motoneuron degenerative disease that is challenging to diagnose and presents with considerable variability in survival. Early identification and enhanced understanding of symptomatic patterns could aid in diagnosis and provide an avenue for monitoring disease progression. Use of the mSOD1G93A mouse model provides control of the confounding environmental factors and genetic heterogeneity seen in amyotrophic lateral sclerosis patients, while investigating underlying disease-induced changes. In the present study, we performed a longitudinal behavioral assessment paradigm and identified an early hindlimb symptom, resembling the common gait abnormality foot drop, along with an accompanying forelimb compensatory mechanism in the mSOD1G93A mouse. Following these initial changes, mSOD1 mice displayed a temporary hindlimb compensatory mechanism resembling an exaggerated steppage gait. As the disease progressed, these compensatory mechanisms were not sufficient to sustain fundamental locomotor parameters and more severe deficits appeared. We next applied these initial findings to investigate the inherent variability in B6SJL mSOD1G93A survival. We identified four behavioral variables that, when combined in a cluster analysis, identified two subpopulations with different disease progression rates: a fast progression group and a slow progression group. This behavioral assessment paradigm, with its analytical approaches, provides a method for monitoring disease progression and detecting mSOD1 subgroups with different disease severities. This affords researchers an opportunity to search for genetic modifiers or other factors that likely enhance or slow disease progression. Such factors are possible therapeutic targets with the potential to slow disease progression and provide insight into the underlying pathology and disease mechanisms.

Indexed as

amyotrophic lateral sclerosisdisease progressiondisease variabilitylocomotormotoneuron degenerative diseasenerve regenerationneural regenerationSOD1 mouse

Identifiers

PMID29171432
PMCPMC5696848
OpenAlexW2766496211

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.